TRP-8802

psilocybin · TRYP Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TRP-8802, covering 2024-11-19 to 2026-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Assessment of Psilocybin (TRP-8802) in Concert With Psychotherapy in Patients With Irritable Bowel Syndrome (IBS) [Phase 2]

See pricing